Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

KORU Medical Systems, Inc. - Common Stock (NQ: KRMD )

4.090 +0.090 (+2.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about KORU Medical Systems, Inc. - Common Stock

< Previous 1 2 3 Next >
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Upcoming Investor Conferences
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces 2022 Third Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Participate in Upcoming Industry Conferences
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems Announces 2022 Second Quarter Financial Results
From KORU Medical Systems, Inc.
Via Business Wire
KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Announces 2022 First Quarter Financial Results
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®
From KORU Medical Systems
Via Business Wire
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022
From KORU Medical Systems
Via Business Wire
KORU Medical Systems Appoints Brian Case As Chief Technology Officer
From KORU Medical Systems
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.